FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,235 | -41.9% | 72,247 | -18.2% | 0.00% | – |
| Q2 2023 | $622,111 | +7.2% | 88,368 | -5.6% | 0.00% | – |
| Q1 2023 | $580,115 | -69.8% | 93,567 | -69.0% | 0.00% | – |
| Q4 2022 | $1,923,991 | -78.4% | 301,566 | -70.9% | 0.00% | -100.0% |
| Q3 2022 | $8,890,000 | -46.5% | 1,036,115 | -15.2% | 0.00% | -50.0% |
| Q2 2022 | $16,612,000 | +6.0% | 1,221,462 | +18.7% | 0.00% | 0.0% |
| Q1 2022 | $15,668,000 | +24.1% | 1,028,726 | +86.4% | 0.00% | 0.0% |
| Q4 2021 | $12,622,000 | -7.5% | 551,905 | -43.6% | 0.00% | 0.0% |
| Q3 2021 | $13,641,000 | +30.4% | 979,227 | -0.1% | 0.00% | +100.0% |
| Q2 2021 | $10,460,000 | +101.5% | 980,209 | +149.0% | 0.00% | 0.0% |
| Q1 2021 | $5,190,000 | +498.6% | 393,722 | +821.1% | 0.00% | – |
| Q4 2020 | $867,000 | – | 42,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |